XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2008-01172
- Event Type
- Injury
- Date Received
- November 19, 2008
- Date of Event
- October 1, 2008
- Report Date
- October 24, 2008
- Manufacturer
- ABBOTT VASCULAR-CARDIAC THERAPIES
- Product Code
- NIQ
- PMA / PMN Number
- P070015
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE SECOND XIENCE V (PART# 1009551-18/LOT# 70227P5) IS BEING FILED UNDER THE SAME MFR NUMBER. RESULTS AND CONCLUSION SUMMATION - PRODUCT PERFORMANCE ENGINEERING REVIEWED THE INCIDENT. ANGINA, AS LISTED IN THE INSTRUCTIONS FOR USE AND PRODUCT RISK ASSESSMENT (RAM), IS A KNOWN RISK ASSOCIATED WITH CORONARY STENTING. DIAPHORESIS (SWEATING) AND HOSPITALIZATION ARE LISTED IN THE RAM AS NO-FAULT POST-PROCEDURE COMPLICATIONS. THERE DOES NOT APPEAR TO BE ANY INDICATIONS OF A STENT DELIVERY SYSTEM QUALITY PROBLEM. A CONCLUSIVE ROOT CAUSE FOR THE REPORTED PT ISSUES, AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED.
REPORTING STATUS: SERIOUS INJURY. REPORTING RATIONALE: PT REQUIRED MEDICAL INTERVENTION. DEVICE ISSUE: NO DEVICE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED VIA A TRIAL THAT APPROX 14 MOS AFTER THE TWO 2.5X18MM XIENCE V STENTS WERE IMPLANTED, THE PT EXPERIENCED ANGINA, NAUSEA AND DIAPHORESIS (SWEATING). A DIAGNOSTIC CORONARY ANGIOGRAPHY WAS DONE AND REVASCULARIZATION WAS PERFORMED AND A PROMUS STENT WAS PLACED IN THE DISTAL LAD. NO ADD'L EVENT OR PT INFO IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM | NIQ | ABBOTT VASCULAR-CARDIAC THERAPIES | NA | 70227P5 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Hospitalization| R | XIENCE V 2.5X18MM (PART# 1009551-18/LOT# 70227P5) |